Pre-Surgical Grading System of Asherman Syndrome
Asherman Syndrome: Pre-surgical Grading to Improve Gauge Prognostic Values and Improve Outcomes
1 other identifier
observational
65
1 country
1
Brief Summary
Utilising a novel pre-surgical grading system to class cases of asherman syndrome into 3 groups based on expected difficulty of surgery and potential prognostic outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2023
CompletedFirst Submitted
Initial submission to the registry
June 4, 2023
CompletedFirst Posted
Study publicly available on registry
June 13, 2023
CompletedJune 13, 2023
June 1, 2023
3.1 years
June 4, 2023
June 4, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage Resumption of normal cavity on hystero-salpingography
assessing the improvement of the cavity of the uterus in hystero-salpingography
1 month
Secondary Outcomes (1)
Menses
3 months
Study Arms (1)
Asherman Patients
Patients diagnosed with Asherman syndrome based on patient complaint of hypomenorrhea or amenorrhea and hysterosalpingography.
Interventions
Eligibility Criteria
Patients complaining of hypomenorrhea, amenorrhea or infertility, who have a hysterosalpingography confirming intrauterine adhesions (Asherman Syndrome)
You may qualify if:
- Asherman Syndrome
- intra-uterine synechiae
You may not qualify if:
- patients with a fundectomy or uterine reduction surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ebtesama Hospital
Cairo, 11341, Egypt
Related Publications (3)
Dreisler E, Kjer JJ. Asherman's syndrome: current perspectives on diagnosis and management. Int J Womens Health. 2019 Mar 20;11:191-198. doi: 10.2147/IJWH.S165474. eCollection 2019.
PMID: 30936754RESULTSalazar CA, Isaacson K, Morris S. A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options. Curr Opin Obstet Gynecol. 2017 Aug;29(4):249-256. doi: 10.1097/GCO.0000000000000378.
PMID: 28582327RESULTDi Guardo F, Della Corte L, Vilos GA, Carugno J, Torok P, Giampaolino P, Manchanda R, Vitale SG. Evaluation and treatment of infertile women with Asherman syndrome: an updated review focusing on the role of hysteroscopy. Reprod Biomed Online. 2020 Jul;41(1):55-61. doi: 10.1016/j.rbmo.2020.03.021. Epub 2020 Apr 28.
PMID: 32444259RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Osama Shawki, MD
Cairo University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Endoscopy unit director
Study Record Dates
First Submitted
June 4, 2023
First Posted
June 13, 2023
Study Start
January 7, 2020
Primary Completion
January 31, 2023
Study Completion
March 15, 2023
Last Updated
June 13, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 1 year after completion
Sharing IPD in an effort to garner more research and interest in the field